Clinical Trials: A Scorecard for Clinical Trial Investigations in 2023
Summary
This report provides an overview of global clinical trials with a start date between January 1, 2023, and December 31, 2023.
Scope
The clinical trials data used for these analyses were extracted from GlobalData’s Clinical Trials Database. The data includes clinical trials with a start date between January 1, 2023 and December 31, 2023, which were captured in the database as of February 14, 2023. The trials were analyzed and segmented by phase, single versus multinational trials, geography, sponsor type (industry versus non-industry), therapy area, indication, top sponsors, molecule type, and top drug trials.
Reasons to Buy
Trends of 2023 trial landscape Comparison to 2022 trial landscape Can view top therapy areas, indications, geographies and sponsors for 2023 trials Designated focus on completed and terminated trials for 2023
Executive Summary
Introduction
Global Clinical Trial Landscape in 2023
Completed Trials in 2023
Clinical Trial Terminations in 2023
Key Findings
Appendix
List of Figures
Figures 1 and 2: Clinical trials by sponsor type, status and initiation/completion
Figures 3 and 4: Clinical trials, by phase and sponsor type